The ophthalmic devices market size has grown strongly in recent years. It will grow from $47.31 billion in 2025 to $51.1 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to rising prevalence of vision impairment, expansion of ophthalmic clinics and hospitals, increasing cataract surgery volumes, growing adoption of corrective vision devices, availability of advanced ophthalmic diagnostics.
The ophthalmic devices market size is expected to see strong growth in the next few years. It will grow to $70.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for age-related eye disease treatments, rising adoption of AI-based ophthalmic diagnostics, expansion of outpatient eye surgery centers, growing focus on preventive eye care, increasing investments in ophthalmic technology innovation. Major trends in the forecast period include increasing adoption of advanced diagnostic ophthalmic imaging, rising use of minimally invasive eye surgery devices, growing integration of digital eye examination tools, expansion of laser-based vision correction systems, enhanced focus on early eye disease detection.
The ophthalmic device market is poised for growth, primarily due to the increasing incidence and prevalence of eye diseases. Eye conditions such as age-related macular degeneration (AMD), glaucoma, and cataracts are becoming significant contributors to visual impairment and blindness on a global scale. Ophthalmic devices are indispensable in the diagnosis, treatment, and management of various eye disorders. For instance, in August 2024, according to the National Health Service (NHS), a public sector organization, NHS-funded sight tests reached a record high of over 841,000 in 2024, marking a 6.6% increase compared to 2023. The growing incidence and prevalence of eye-related disorders are expected to drive the demand for ophthalmic devices in the diagnosis and treatment of eye diseases.
Major companies in the ophthalmic devices market are focusing on developing innovative products to maintain their market standing. They invest in research and development to introduce inventive products and expand their market share. For example, in May 2023, Sight Sciences Inc., a U.S.-based eyecare technology company, announced the development of two innovative ophthalmic systems, both featuring proprietary glaucoma and dry eye technologies such as the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology facilitates minimally invasive, implant-free glaucoma procedures for adults with primary open-angle glaucoma, while the TearCare System offers an interventional eyelid procedure for patients with evaporative dry eye disease due to meibomian gland dysfunction through localized heat therapy.
In July 2024, Bausch + Lomb, a US-based eye health company, acquired Trukera Medical, a US-based diagnostic firm, to expand its footprint in the dry eye segment. Through this acquisition, Bausch + Lomb obtained ScoutPro, a portable tear osmolarity device developed by Trukera, enabling improved point-of-care diagnostics for ocular surface disease and dry eye. Trukera Medical is a US-based company that specializes in developing diagnostic solutions for measuring tear-film osmolarity.
Major companies operating in the ophthalmic devices market are Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health Companies Inc., Carl Zeiss AG, Flex Ltd., Nidek Co. Ltd., Topcon Corporation, Alcon Inc., EssilorLuxottica, Novartis AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Menicon Co. Ltd., Chengdu Kanghong Pharmaceutical, Glaukos Corporation, STAAR Surgical Company, Omeros Corporation, Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Iridex.
North America was the largest region in the global ophthalmic devices market in 2025. Asia-Pacific was the second largest region in the global ophthalmic devices market. Africa. was the smallest region in the global ophthalmic devices market. The regions covered in the ophthalmic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the ophthalmic devices market by increasing costs of imported optical components, imaging sensors, laser systems, surgical instruments, and diagnostic equipment used across eye care applications. Hospitals and eye care centers in North America and Europe are most affected due to reliance on imported precision optics and electronics, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing equipment costs and slowing replacement cycles. However, they are also encouraging domestic production of ophthalmic instruments, regional optical manufacturing, and innovation in cost-effective eye care technologies.
The ophthalmic devices market research report is one of a series of new reports that provides ophthalmic devices market statistics, including ophthalmic devices industry global market size, regional shares, competitors with a ophthalmic devices market share, detailed ophthalmic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic devices industry. This ophthalmic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmology is a medical specialty that focuses on the diagnosis, treatment, and prevention of eye diseases and disorders affecting the visual system. Ophthalmic devices are utilized for the diagnosis and treatment of various eye conditions. Ophthalmologists are medical doctors who specialize in eye care, performing eye exams, prescribing corrective lenses, diagnosing eye diseases, and conducting surgical procedures to address vision-related issues.
The primary categories within the field of ophthalmic devices include vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment, for example, involve the use of devices that emit ultrasound waves to soften and break up the lens, making it easier to remove through suction. Expenditure in this domain can come from both public and private sources, and the products used encompass instruments/equipment and disposables. Ophthalmic devices serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The ophthalmic devices consist of sales of instruments such as optical coherence tomography scanners, perimeters/visual field analyzers, ophthalmic pachymeters, wavefront aberrometers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ophthalmic devices market size is expected to see strong growth in the next few years. It will grow to $70.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for age-related eye disease treatments, rising adoption of AI-based ophthalmic diagnostics, expansion of outpatient eye surgery centers, growing focus on preventive eye care, increasing investments in ophthalmic technology innovation. Major trends in the forecast period include increasing adoption of advanced diagnostic ophthalmic imaging, rising use of minimally invasive eye surgery devices, growing integration of digital eye examination tools, expansion of laser-based vision correction systems, enhanced focus on early eye disease detection.
The ophthalmic device market is poised for growth, primarily due to the increasing incidence and prevalence of eye diseases. Eye conditions such as age-related macular degeneration (AMD), glaucoma, and cataracts are becoming significant contributors to visual impairment and blindness on a global scale. Ophthalmic devices are indispensable in the diagnosis, treatment, and management of various eye disorders. For instance, in August 2024, according to the National Health Service (NHS), a public sector organization, NHS-funded sight tests reached a record high of over 841,000 in 2024, marking a 6.6% increase compared to 2023. The growing incidence and prevalence of eye-related disorders are expected to drive the demand for ophthalmic devices in the diagnosis and treatment of eye diseases.
Major companies in the ophthalmic devices market are focusing on developing innovative products to maintain their market standing. They invest in research and development to introduce inventive products and expand their market share. For example, in May 2023, Sight Sciences Inc., a U.S.-based eyecare technology company, announced the development of two innovative ophthalmic systems, both featuring proprietary glaucoma and dry eye technologies such as the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology facilitates minimally invasive, implant-free glaucoma procedures for adults with primary open-angle glaucoma, while the TearCare System offers an interventional eyelid procedure for patients with evaporative dry eye disease due to meibomian gland dysfunction through localized heat therapy.
In July 2024, Bausch + Lomb, a US-based eye health company, acquired Trukera Medical, a US-based diagnostic firm, to expand its footprint in the dry eye segment. Through this acquisition, Bausch + Lomb obtained ScoutPro, a portable tear osmolarity device developed by Trukera, enabling improved point-of-care diagnostics for ocular surface disease and dry eye. Trukera Medical is a US-based company that specializes in developing diagnostic solutions for measuring tear-film osmolarity.
Major companies operating in the ophthalmic devices market are Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health Companies Inc., Carl Zeiss AG, Flex Ltd., Nidek Co. Ltd., Topcon Corporation, Alcon Inc., EssilorLuxottica, Novartis AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Menicon Co. Ltd., Chengdu Kanghong Pharmaceutical, Glaukos Corporation, STAAR Surgical Company, Omeros Corporation, Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Iridex.
North America was the largest region in the global ophthalmic devices market in 2025. Asia-Pacific was the second largest region in the global ophthalmic devices market. Africa. was the smallest region in the global ophthalmic devices market. The regions covered in the ophthalmic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the ophthalmic devices market by increasing costs of imported optical components, imaging sensors, laser systems, surgical instruments, and diagnostic equipment used across eye care applications. Hospitals and eye care centers in North America and Europe are most affected due to reliance on imported precision optics and electronics, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing equipment costs and slowing replacement cycles. However, they are also encouraging domestic production of ophthalmic instruments, regional optical manufacturing, and innovation in cost-effective eye care technologies.
The ophthalmic devices market research report is one of a series of new reports that provides ophthalmic devices market statistics, including ophthalmic devices industry global market size, regional shares, competitors with a ophthalmic devices market share, detailed ophthalmic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic devices industry. This ophthalmic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmology is a medical specialty that focuses on the diagnosis, treatment, and prevention of eye diseases and disorders affecting the visual system. Ophthalmic devices are utilized for the diagnosis and treatment of various eye conditions. Ophthalmologists are medical doctors who specialize in eye care, performing eye exams, prescribing corrective lenses, diagnosing eye diseases, and conducting surgical procedures to address vision-related issues.
The primary categories within the field of ophthalmic devices include vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment, for example, involve the use of devices that emit ultrasound waves to soften and break up the lens, making it easier to remove through suction. Expenditure in this domain can come from both public and private sources, and the products used encompass instruments/equipment and disposables. Ophthalmic devices serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The ophthalmic devices consist of sales of instruments such as optical coherence tomography scanners, perimeters/visual field analyzers, ophthalmic pachymeters, wavefront aberrometers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ophthalmic Devices Market Characteristics
3. Ophthalmic Devices Market Supply Chain Analysis
4. Global Ophthalmic Devices Market Trends and Strategies
5. Ophthalmic Devices Market Analysis of End Use Industries
7. Global Ophthalmic Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ophthalmic Devices Total Addressable Market (TAM) Analysis for the Market
9. Ophthalmic Devices Market Segmentation
10. Ophthalmic Devices Market Regional and Country Analysis
11. Asia-Pacific Ophthalmic Devices Market
12. China Ophthalmic Devices Market
13. India Ophthalmic Devices Market
14. Japan Ophthalmic Devices Market
15. Australia Ophthalmic Devices Market
16. Indonesia Ophthalmic Devices Market
17. South Korea Ophthalmic Devices Market
18. Bangladesh Ophthalmic Devices Market
19. Thailand Ophthalmic Devices Market
20. Vietnam Ophthalmic Devices Market
21. Malaysia Ophthalmic Devices Market
22. Singapore Ophthalmic Devices Market
23. Philippines Ophthalmic Devices Market
24. Hong Kong Ophthalmic Devices Market
25. New Zealand Ophthalmic Devices Market
26. Taiwan Ophthalmic Devices Market
27. South East Asia Ophthalmic Devices Market
28. Western Europe Ophthalmic Devices Market
29. UK Ophthalmic Devices Market
30. Germany Ophthalmic Devices Market
31. France Ophthalmic Devices Market
32. Italy Ophthalmic Devices Market
33. Spain Ophthalmic Devices Market
34. Austria Ophthalmic Devices Market
35. Belgium Ophthalmic Devices Market
36. Denmark Ophthalmic Devices Market
37. Finland Ophthalmic Devices Market
38. Ireland Ophthalmic Devices Market
39. Netherlands Ophthalmic Devices Market
40. Norway Ophthalmic Devices Market
41. Portugal Ophthalmic Devices Market
42. Sweden Ophthalmic Devices Market
42. Switzerland Ophthalmic Devices Market
43. Eastern Europe Ophthalmic Devices Market
44. Russia Ophthalmic Devices Market
45. Czech Republic Ophthalmic Devices Market
46. Poland Ophthalmic Devices Market
47. Romania Ophthalmic Devices Market
48. Ukraine Ophthalmic Devices Market
49. North America Ophthalmic Devices Market
50. USA Ophthalmic Devices Market
51. Canada Ophthalmic Devices Market
52. Mexico Ophthalmic Devices Market
53. South America Ophthalmic Devices Market
54. Brazil Ophthalmic Devices Market
55. Chile Ophthalmic Devices Market
56. Argentina Ophthalmic Devices Market
57. Colombia Ophthalmic Devices Market
58. Peru Ophthalmic Devices Market
59. Middle East Ophthalmic Devices Market
60. Saudi Arabia Ophthalmic Devices Market
61. Israel Ophthalmic Devices Market
62. Iran Ophthalmic Devices Market
63. Turkey Ophthalmic Devices Market
64. United Arab Emirates Ophthalmic Devices Market
65. Africa Ophthalmic Devices Market
66. Egypt Ophthalmic Devices Market
67. Nigeria Ophthalmic Devices Market
68. South Africa Ophthalmic Devices Market
70. Ophthalmic Devices Market Competitive Landscape and Company Profiles
71. Ophthalmic Devices Market Other Major and Innovative Companies
74. Ophthalmic Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Ophthalmic Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ophthalmic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ophthalmic devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device: Vision Care Devices And Equipment; Cataract Surgery Devices And Equipment; Refractive Surgery Devices And Equipment; Diagnostic And Monitoring Ophthalmic Devices And Equipment2) By Product: Instruments Or Equipment; Disposables
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
4) By Type of Expenditure: Public; Private
Subsegments:
1) By Vision Care Devices And Equipment: Eyeglasses; Contact Lenses; Low Vision Aids2) By Cataract Surgery Devices And Equipment: Cataract Surgery Instruments; Cataract Surgery Implants (Intraocular Lenses); Cataract Surgery Devices (Phacoemulsification Systems)
3) By Refractive Surgery Devices And Equipment: LASIK Devices; SMILE Surgery Devices; PRK Surgery Devices
4) By Diagnostic And Monitoring Ophthalmic Devices And Equipment: Fundus Cameras; Optical Coherence Tomography (OCT) Scanners; Perimeters; Retinal Imaging Systems; Slit Lamps
Companies Mentioned: Luxottica Group S.p.A.; Johnson & Johnson; Hoya Corporation; CooperVision AG; Bausch Health Companies Inc.; Carl Zeiss AG; Flex Ltd.; Nidek Co. Ltd.; Topcon Corporation; Alcon Inc.; EssilorLuxottica; Novartis AG; Regeneron Pharmaceuticals Inc.; Roche Holding AG; Santen Pharmaceutical Co. Ltd.; Rohto Pharmaceutical Co. Ltd.; Menicon Co. Ltd.; Chengdu Kanghong Pharmaceutical; Glaukos Corporation; STAAR Surgical Company; Omeros Corporation; Aerie Pharmaceuticals Inc.; Alimera Sciences Inc.; Iridex
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ophthalmic Devices market report include:- Luxottica Group S.p.A.
- Johnson & Johnson
- Hoya Corporation
- CooperVision AG
- Bausch Health Companies Inc.
- Carl Zeiss AG
- Flex Ltd.
- Nidek Co. Ltd.
- Topcon Corporation
- Alcon Inc.
- EssilorLuxottica
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Santen Pharmaceutical Co. Ltd.
- Rohto Pharmaceutical Co. Ltd.
- Menicon Co. Ltd.
- Chengdu Kanghong Pharmaceutical
- Glaukos Corporation
- STAAR Surgical Company
- Omeros Corporation
- Aerie Pharmaceuticals Inc.
- Alimera Sciences Inc.
- Iridex
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 51.1 Billion |
| Forecasted Market Value ( USD | $ 70.19 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
